0001382963-19-000119.txt : 20191107 0001382963-19-000119.hdr.sgml : 20191107 20191107204413 ACCESSION NUMBER: 0001382963-19-000119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191107 FILED AS OF DATE: 20191107 DATE AS OF CHANGE: 20191107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Georgiadis Anna CENTRAL INDEX KEY: 0001789559 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38238 FILM NUMBER: 191201873 MAIL ADDRESS: STREET 1: 235 YORKLAND BLVD. STREET 2: SUITE 900 CITY: TORONTO STATE: A6 ZIP: M2J 4Y8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Venus Concept Inc. CENTRAL INDEX KEY: 0001409269 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 061681204 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 235 YORKLAND BLVD. STREET 2: SUITE 900 CITY: TORONTO STATE: A6 ZIP: M2J 4Y8 BUSINESS PHONE: 877-848-8430 X117 MAIL ADDRESS: STREET 1: 235 YORKLAND BLVD. STREET 2: SUITE 900 CITY: TORONTO STATE: A6 ZIP: M2J 4Y8 FORMER COMPANY: FORMER CONFORMED NAME: Restoration Robotics, Inc. DATE OF NAME CHANGE: 20171121 FORMER COMPANY: FORMER CONFORMED NAME: Restoration Robotics Inc DATE OF NAME CHANGE: 20070808 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-11-07 0001409269 Venus Concept Inc. VERO 0001789559 Georgiadis Anna C/O VENUS CONCEPT INC. 235 YORKLAND BLVD., SUITE 900 TORONTO A6 M2J 4Y8 ONTARIO, CANADA 0 1 0 0 VP, Global Human Resources Employee Stock Options (right to buy) 7.95 2019-11-07 4 A 0 28835 A 2028-09-28 Common Stock 28835 28835 D As of the Transaction Date, 7,808 of these options to acquire Common Stock of the Issuer are fully vested and exercisable. The remaining balance of 21,027 options vest ratably and become exercisable each month from November 28, 2019 to September 28, 2022. Received, in connection with the merger of a wholly-owned subsidiary of Restoration Robotics, Inc. with and into Venus Concept Ltd. in exchange for an employee stock option to acquire 50,000 Venus Concept Ltd. ordinary shares with an original exercise price of $4.57 per share. /s/ Domenic Di Sisto, attorney-in-fact 2019-11-07